| $1.590 | +87.28% | 19.56M | TPET shares surged due to rising oil prices and a significant recovery from a prior drop. |
| $3.020 | +79.76% | 33.27M | Veeva Systems' strong Q4 earnings report boosted TURB's stock price despite broader market declines. |
| $1.000 | +62.10% | 19.21M | STAK rebounded sharply by +35.51% after a significant -41.82% drop the previous day. |
| $0.642 | +55.41% | 67.22M | IBO's stock surged 65% after revising its merger agreement, boosting investor confidence. |
| $4.020 | +54.62% | 310.78M | Alto reported a significant profit improvement with Q4 earnings of $21 million, boosting investor confidence. |
| $1.810 | +45.97% | 15.64M | Gaxos.ai shares surged 85% due to licensing news for drone technology. |
| $17.600 | +41.25% | 201.70M | CPI Card Group's Q4 EPS beat expectations, driving a positive stock price movement for PMTS. |
| $0.819 | +40.94% | 177.38M | Tenaya signed a $1.13 billion deal with Alnylam for heart disease treatments, boosting investor confidence. |
| $0.445 | +40.35% | 6.02M | CDT Environmental Technology surged 42% after an SEC filing to raise $6.51 million through share sales. |
| $3.040 | +37.56% | 71.64M | Positive sentiment from U.S. job data contributed to TMDE's significant stock price increase. |
| $10.500 | +37.43% | 42.67M | Positive news about NCI boosted investor confidence, leading to an 18.06% stock price rise. |
| $13.850 | +37.26% | 2.04B | Cooper Creek Partners sold all shares of Sable Offshore, indicating a loss of confidence. |
| $16.830 | +36.28% | 2.40B | Erasca's collaboration with Tango for clinical trials boosts confidence in TNGX's potential. |
| $9.960 | +34.05% | 463.09M | Palladyne AI's projected revenue growth of 357% to 415% significantly boosted investor confidence. |
| $1.090 | +29.92% | 5.59M | GBR's stock surged due to positive news amidst a struggling sector and broader market declines. |
| $19.150 | +28.52% | 424.84M | Veeva Systems' strong Q4 results raised FY27 guidance, boosting investor confidence in NPT's stock. |
| $1.150 | +27.77% | 7.11M | Olenox initiated its 2026 drilling program, boosting investor confidence and stock performance. |
| $0.0372 | +27.30% | 4.20M | Blue Hat's reverse stock split plan was postponed, enhancing liquidity and attracting investors. |
| $0.680 | +25.93% | 17.54M | Upcoming Q4 earnings announcement with improved EPS expectations is a key price-driven event. |
| $10.705 | +23.76% | 135.32M | Expanse Studios launched a Bonus Bet feature, positively impacting MRDN's stock performance. |
| $3.460 | +23.57% | 95.15M | -- |
| $0.710 | +23.48% | 22.02M | -- |
| $13.120 | +21.48% | 26.84M | Positive news about MXC sparked significant investor interest, driving the stock price up by 33.75%. |
| $12.180 | +21.19% | 103.40M | Stem's stock rose 21.13% ahead of its Q4 earnings announcement on March 4. |
| $15.530 | +20.67% | 80.75M | -- |
| $0.738 | +20.17% | 4.02M | -- |
| $1.750 | +19.86% | 8.62M | -- |
| $3.840 | +19.25% | 255.95M | ANNA's stock surged 17.08% despite broader market declines and many sector losers. |
| $0.610 | +19.15% | 30.48M | EONR's stock rebounded +22.12% after a significant -20.02% drop the previous day. |
| $2.500 | +19.05% | 211.03M | -- |
| $14.890 | +18.65% | 2.00B | Amprius reported Q4 revenue of $25.23 million, up 137.3% YoY, beating expectations. |
| $1.080 | +18.43% | 32.86M | KNRX surged 26.14% despite broader market declines and a prior significant drop. |
| $29.790 | +18.36% | 14.18B | TTD shares surged 19% after reports of OpenAI's advertising partnership discussions. |
| $8.260 | +18.00% | 69.38M | -- |
| $10.650 | +17.81% | 665.94M | uniQure reported strong Q4 results, beating loss estimates and exceeding sales expectations. |
| $13.000 | +17.65% | 579.44M | -- |
| $0.600 | +17.42% | 72.99M | -- |
| $6.350 | +17.38% | 108.93M | -- |
| $3.640 | +17.04% | 419.66M | NovaBridge's VIS-101 clinical data update shows promising results, boosting investor confidence significantly. |
| $1.260 | +16.67% | 113.81M | Codexis signed a significant agreement for siRNA production, boosting stock price and market positioning. |
| $0.554 | +16.63% | 14.12M | Recent product launches and partnerships positively influenced investor sentiment, driving SKYQ's stock price up. |
| $3.910 | +16.37% | 57.76M | -- |
| $0.948 | +16.17% | 21.23M | Positive Phase 1 trial results for LYMPHIR show an 86% overall response rate, boosting investor confidence. |
| $0.553 | +15.92% | 12.08M | FTRK's stock rose 4.80% due to a $3 million partnership with KIIRAS. |
| $4.910 | +15.80% | 1.96B | Recent positive news sparked significant investor interest, driving BAK's stock price up by +14.86%. |
| $4.680 | +15.41% | 4.53M | -- |
| $1.350 | +15.38% | 6.59M | -- |
| $0.469 | +14.67% | 12.04M | -- |
| $2.090 | +14.21% | 16.87M | MTEK's stock surged +48.63% despite a weak sector and declining market indices. |
| $34.730 | +14.06% | 1.83B | -- |